Who is sponsoring NCT01479478?

NCT01479478 is sponsored by Stanford University.

What condition does NCT01479478 study?

NCT01479478 studies Infection, Pregnancy.

What drugs are being tested in NCT01479478?

Interventions: Placebo, Probiotic dietary supplement.

What is the status of NCT01479478?

NCT01479478 is currently COMPLETED.

Last reviewed 2018-08-14 · How we verify

Oral Probiotic Supplementation and Group B Streptococcus Rectovaginal Colonization in Pregnant Women: a Randomized Double-blind Placebo-controlled Trial.

NCT01479478 NA COMPLETED Results posted

The investigators wish to determine if oral probiotic supplementation during the second half of pregnancy decreases maternal GBS recto-vaginal colonization at 35-37 weeks' gestational age, thereby decreasing need for maternal antibiotic administration at time of labor. The importance of this study is that it may offer a safer alternative to antibiotic treatment of group B Streptococcus (GBS) colonized pregnant women.

Details

Lead sponsor	Stanford University
Phase	NA
Status	COMPLETED
Enrolment	251
Start date	2011-11
Completion	2017-07-26

Conditions

Infection
Pregnancy

Interventions

Placebo
Probiotic dietary supplement

Primary outcomes

Count of Participants With Positive Group B Streptococcus Rectovaginal Colonization Status at 35- 37 Weeks' Gestational Age — 35 to 37 weeks gestational age
Gestational age is given in a format of full weeks.

Countries

United States